Daniela Modena
Preclinical R&D
Milan, Italy
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors.
Journal: Neuroendocrinology
Published: September 27, 2024
In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy.
Journal: European journal of medicinal chemistry
Published: July 03, 2024
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Journal: International journal of molecular sciences
Published: February 08, 2024
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.
Journal: Journal of medicinal chemistry
Published: November 12, 2019
Octreotide Conjugates for Tumor Targeting and Imaging.
Journal: Pharmaceutics
Published: March 27, 2019
Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.
Journal: The Journal of biological chemistry
Published: December 03, 2014
Modulation of gamma globin genes expression by histone deacetylase inhibitors: an in vitro study.
Journal: British journal of haematology
Published: October 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026